ClinConnect ClinConnect Logo
Search / Trial NCT06878326

Resting-State Functional Connectivity As a Predictor of TDCS Effects in Adolescents with Autism Spectrum Disorder

Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Mar 11, 2025

Trial Information

Current as of April 29, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring the effects of a treatment called Transcranial Direct Current Stimulation (tDCS) on adolescents with Autism Spectrum Disorder (ASD). tDCS is a safe and non-invasive method that uses a mild electrical current to stimulate specific areas of the brain. The researchers want to find out if tDCS can improve learning and cognitive abilities in young people with ASD, and to understand how it works in the brain. They will also look at whether certain brain activity patterns, measured before treatment, can predict how well participants respond to tDCS.

To participate, individuals must be between 12 and 22 years old and have a confirmed diagnosis of ASD. They should be able to communicate in Chinese and not have any other major neurological or psychiatric issues. During the trial, participants will receive different types of tDCS or a placebo treatment (sham-tDCS) while completing some cognitive tests. The study aims to help improve understanding of how brain stimulation can benefit adolescents with ASD, which could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • being 12-22 years old
  • diagnosed with ASD given by registered psychiatrists or clinical psychologists according to the Diagnostic and Statistical Manual of Mental Disorders-5th Edition (DSM-5) criteria of ASD
  • able to communicate in Chinese
  • Exclusion Criteria:
  • without a confirmed diagnosis from the clinical psychologist
  • history of other neurological and psychiatric disorders and head trauma
  • on psychiatric medication

About The Hong Kong Polytechnic University

The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

Yvonne Han, PhD

Principal Investigator

The Hong Kong Polytechnic University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported